Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma - BeOne

Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma

BeOne Study ID

BGB-HNSCC-201

ClinicalTrials.gov ID

NCT05909904

China Drug Trials ID

CTR20232123

Study Overview

Sex: All

Age: 18 Years / N/A

No Study Documents

Study Overview

Sex: All

Age: 18 Years / N/A

No Study Documents